CleveMed Releases Web Portal API

Jul 9, 2014

CleveMed, a leader in Home Sleep Testing equipment and cloud based services, announced today that it has released the SleepViewSM Web Portal API. You might be asking “what is an api?” – API stands for Application Programming Interface and it is essentially a software that allows two applications to talk to each other. API software is something a lot of businesses use to have all of their other software communicate with one another so that business operations run smoothly. Businesses will often reach out to Apica Systems and companies alike for bespoke API systems so that they can work as efficiently as possible. In this case, the API will allow sleep diagnostic data to be shared with Electronic Medical Records (EMRs) and cloud-based Obstructive Sleep Apnea (OSA) treatment solutions. SleepView® Monitor integrates with a cloud-based monitoring technology to allow healthcare providers to test patients suspected of OSA in their own homes. This Home Sleep Testing (HST) method is far more convenient and costs about one fourth the expense of in-lab evaluation.

“Sharing our data with EMRs will allow our customers to more easily demonstrate cost savings and clinical benefit generated from their sleep apnea care. This is particularly beneficial to larger physician groups such as Accountable Care Organizations

[ACO] whose revenue can be enhanced with improved population health management”, said Sarah Weimer, CleveMed Director of Sleep Products.
Another advantage to EMR integration is improved sleep apnea care workflow within the practice. “Unlike current sleep apnea diagnostic and treatment systems where only sleep apnea reports are statically stored within the EMR, if at all, our API will allow a more intimate and dynamic flow of data that will minimize double entry for the practice staff, and enhance querying of results from within the EMR itself”, said Ilya Gotfryd, Director of Information Systems at CleveMed.

OSA, the most prevalent form of sleep apnea, is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, up to 80 percent of the population with the disease is undiagnosed and untreated. OSA does hold serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries. As importantly, many studies have shown that treating OSA can improve the clinical outcome of many comorbidities and therefore reduce overall healthcare costs significantly.

CleveMed is a leader in portable sleep monitoring and web-based technologies. CleveMed has developed a growing range of products that address the needs of patients with sleep disorders, including Sapphire PSG™, SleepScout™, SleepView® and SleepViewSM web portal. CleveMed’s cloud-based solutions allow home sleep studies to be initiated directly from the physician’s practice, which is convenient to patients, speeds the diagnosis and treatment for providers, and reduces healthcare costs to payers. For more information, please (Follow us on Twitter, Youtube, LinkedIn, and Facebook). SleepView is a registered trademark and a service mark; and Sapphire PSG and SleepScout are trademarks of Cleveland Medical Devices Inc. of Cleveland, OH.

For More Information Contact:
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720